Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
J Clin Exp Hepatol
; 12(3): 841-852, 2022.
Article
in En
| MEDLINE
| ID: mdl-35677513
AFP, Alfa-fetoprotein; BCLC, Barcelona clinic liver cancer; BSC, Best supportive care; Barcelona clinic liver cancer staging; EHM, Extrahepatic metastasis; HBHC, HBV or HCV related; HBV, Hepatitis B virus; HCC, Hepatocellular carcinoma; HCV, Hepatitis C virus; MDT, Multidisciplinary team; MTD, Maximum tumor diameter; NAFLD, Nonalcoholic fatty liver disease; NBNC, Non B Non C related; OS, Overall survival; PVTT, Portal vein tumor thrombosis; RFA, Radiofrequency ablation; SBRT, Stereotactic body radiation therapy; TACE, Transarterial chemo-embolization; TARE, Transarterial radio-embolization; alfa-fetoprotein; biomarker; hepatocellular carcinoma; portal vein tumor thrombosis
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Prognostic_studies
Language:
En
Journal:
J Clin Exp Hepatol
Year:
2022
Document type:
Article
Affiliation country:
India
Country of publication:
India